Clinical Trials Directory

Trials / Completed

CompletedNCT01642745

Mannitol (Aridol) and Methacholine (Provocholine) Responsiveness

Mannitol and Methacholine Responsiveness: Effects of Deep Inhalations

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
20 (actual)
Sponsor
University of Saskatchewan · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The study will compare the airway responses to two bronchoconstricting agents, mannitol and methacholine.

Conditions

Interventions

TypeNameDescription
DRUGMethacholine (Provocholine)two minutes of aerosol inhalation of concentrations of methacholine ranging from 0.03 - 256mg/mL
DRUGMannitol (Aridol)single deep inhalation of dry powder per dose doses range from 0mg - 160mg (cumulative dose range 0mg-635mg).
DRUGMethacholine (Provocholine)two minutes of aerosol inhalation of concentrations of methacholine ranging from 0.03 - 256mg/mL every 20 seconds a deep inhalation is performed

Timeline

Start date
2011-11-01
Primary completion
2013-02-01
Completion
2013-02-01
First posted
2012-07-17
Last updated
2016-10-27

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01642745. Inclusion in this directory is not an endorsement.